ZA751949B - Highly attenuated cytomegalovirus vaccine and production thereof - Google Patents

Highly attenuated cytomegalovirus vaccine and production thereof

Info

Publication number
ZA751949B
ZA751949B ZA00751949A ZA751949A ZA751949B ZA 751949 B ZA751949 B ZA 751949B ZA 00751949 A ZA00751949 A ZA 00751949A ZA 751949 A ZA751949 A ZA 751949A ZA 751949 B ZA751949 B ZA 751949B
Authority
ZA
South Africa
Prior art keywords
production
highly attenuated
cytomegalovirus vaccine
attenuated cytomegalovirus
vaccine
Prior art date
Application number
ZA00751949A
Other languages
English (en)
Inventor
S Plotkin
Original Assignee
Wistar Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Inst filed Critical Wistar Inst
Publication of ZA751949B publication Critical patent/ZA751949B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA00751949A 1974-04-15 1975-03-27 Highly attenuated cytomegalovirus vaccine and production thereof ZA751949B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/460,951 US3959466A (en) 1974-04-15 1974-04-15 Highly attenuated cytomegalovirus vaccine and production thereof

Publications (1)

Publication Number Publication Date
ZA751949B true ZA751949B (en) 1976-02-25

Family

ID=23830680

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00751949A ZA751949B (en) 1974-04-15 1975-03-27 Highly attenuated cytomegalovirus vaccine and production thereof

Country Status (11)

Country Link
US (1) US3959466A (US07122547-20061017-C00273.png)
JP (1) JPS58406B2 (US07122547-20061017-C00273.png)
BE (1) BE827572A (US07122547-20061017-C00273.png)
CA (1) CA1045546A (US07122547-20061017-C00273.png)
CH (1) CH617588A5 (US07122547-20061017-C00273.png)
DE (1) DE2516274C2 (US07122547-20061017-C00273.png)
FR (1) FR2267117B1 (US07122547-20061017-C00273.png)
GB (1) GB1501724A (US07122547-20061017-C00273.png)
NL (1) NL7504480A (US07122547-20061017-C00273.png)
SE (1) SE7504221L (US07122547-20061017-C00273.png)
ZA (1) ZA751949B (US07122547-20061017-C00273.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058598A (en) * 1974-10-18 1977-11-15 Harold Stern Cytomegalovirus attenuation method and vaccine
AU532186B2 (en) * 1978-07-21 1983-09-22 Merck & Co., Inc. Herpes virus vaccine
US6133433A (en) * 1984-07-27 2000-10-17 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US6242567B1 (en) 1984-07-27 2001-06-05 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
US5248768A (en) * 1986-11-24 1993-09-28 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus
EP0277773A1 (en) * 1987-01-30 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University Hybrid cytomegalovirus (CMV) and vaccine
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
AU2809897A (en) 1996-04-23 1997-11-12 Wistar Institute Of Anatomy And Biology, The Novel human cytomegalovirus dna constructs and uses therefor
US6835383B2 (en) 2000-03-23 2004-12-28 City Of Hope Protein kinase deficient, immunologically active CMVpp65 mutants
EP1178111A1 (en) * 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US9439960B2 (en) * 2007-10-10 2016-09-13 The Trustees Of Princeton University Cytomegalovirus vaccines and methods of production
WO2021014398A1 (en) 2019-07-23 2021-01-28 University Of Rijeka Faculty Of Medicine Integrated human cytomegalovirus / glioblastoma vaccine

Also Published As

Publication number Publication date
CA1045546A (en) 1979-01-02
AU8002475A (en) 1976-10-14
NL7504480A (nl) 1975-10-17
US3959466A (en) 1976-05-25
JPS58406B2 (ja) 1983-01-06
GB1501724A (en) 1978-02-22
CH617588A5 (US07122547-20061017-C00273.png) 1980-06-13
SE7504221L (sv) 1975-12-22
DE2516274A1 (de) 1975-10-23
DE2516274C2 (de) 1986-10-30
JPS5115612A (US07122547-20061017-C00273.png) 1976-02-07
FR2267117A1 (US07122547-20061017-C00273.png) 1975-11-07
FR2267117B1 (US07122547-20061017-C00273.png) 1978-11-24
BE827572A (fr) 1975-10-06

Similar Documents

Publication Publication Date Title
ZA746599B (en) Inhaler
ZA751949B (en) Highly attenuated cytomegalovirus vaccine and production thereof
JPS511905A (en) M sokoryuki
ZA755929B (en) Aminobenzazocines and preparation thereof
IL47535A (en) 7-methoxy-6-thiatetracyclines and their preparation
GB1520149A (en) 4-methylthio-2-trifluoromethylmethanesulphonanilide and deivatives thereof
IL46426A0 (en) Influenza vaccines and their production
JPS512528A (en) Hyomenso o kaizenshita enpitsu no renzokutekiseizohoho
GB1516118A (en) 2-haloethyl-phosphonates and phosphonodithioates
JPS5129456A (en) Kogakukatsusei oo benjiruserinjudotai no seiho
ZA751074B (en) Substituted diaminoguanidines and their manufacture
AU489998B2 (en) Highly attenuated cytomegalovirus vaccine and production thereof
JPS5137323A (en) O2 sensashutsuryokuhoseihoho
AU503647B2 (en) Antipregnancy vaccine
KR790000968Y1 (en) Fire senser
JPS5124852A (en) Deruta m hoshikianarogumemori
GB1486847A (en) Carboxy-cyproheptadines their preparation and use
ZA755816B (en) Thiamindisulphide-orotate and process for its preparation
JPS5124064A (en) Parupukokuekino sanso nyoru shorihoho
JPS5120263A (en) Ototsu moyo o jusuru goseijushishiito no seizohoho
JPS5130882A (en) O ringu no teionseikairyohoho
JPS5149429A (en) Sanso x senyohenatsuki
MW5375A1 (en) Penam compounds and preparation thereof
PH12846A (en) 3-benzazocine and preparation thereof
ZA75667B (en) Phenoxyalkylamines and their preparation